Хронический панкреатит: как долго лечить и чего при этом ожидать?


Ю.А. Кучерявый

Кафедра пропедевтики внутренних болезней и гастроэнтерологии ГБОУ ВПО “МГМСУ им. А.И. Евдокимова” Минздравсоцразвития России, Москва
Хронический панкреатит (ХП) – заболевание с выраженной неоднородностью патологического процесса и клинических проявлений. База доказательности класса (уровня) I для диагностики и терапевтического лечения отсутствует. Несмотря на недостаточную научную обоснованность, в мире имеются различные национальные стандарты консервативного ведения ХП, на основании которых и сформирован данный обзор с акцентом на отечественное здравоохранение и учетом возможностей и проблем практикующих врачей в России сегодня.

Литература


1. Frulloni L, Falconi M, Gabbrielli, et al. Italian consensus guidelines for chronic pancreatitis. Dig Liver Dis2010;42(6):381–406.


2. Bornman PC, Botha JF, Ramos JM, et al. Guideline for the diagnosis and treatment of chronic pancreatitis. S Afr Med J 2010;100(12 Pt 2):845–60.


3. Guidelines for the diagnosis and treatment of chronic pancreatitis (Nanjing, 2005). Chin J Dig Dis 2005;6:198–201.


4. Warshaw AL, Banks PA, Fernandez-Del Castillo C. AGA technical review: treatment of pain in chronic pancreatitis. Gastroenterology 1998;115:765–76.


5. Tandon RK, Sato N, Garg PK. Chronic pancreatitis: Asia-Pacific consensus report. J GastroenterolHepatol 2002;17:508–18.


6. Schneider A, Luhr JM, Singer MV. The M-ANNHEIM Classification of Chronic Pancreatitis: Introduction of a unifying classification system based on a review of previous classifications of the disease. JGastroenterology 2007;42:101–19.


7. Talamini G, Bassi C, Falconi M, et al. Alcohol and smoking as risk factors in chronic pancreatitis and pancreatic cancer. Dig Dis Sci 1999;44:1301–11.


8. Lin Y, Tamakoshi A, Hayakawa T, et al. Cigarette smoking as a risk factor for chronic pancreatitis: a case-control study in Japan. Research Committee on Intractable Pancreatic Diseases. Pancreas 2000;21:109–14.


9. Whitcomb DC, Gorry MC, Preston RA, et al. Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene. Nat Genet1996;14:141–45.


10. Sharer N, Schwarz M, Malone G, et al. Mutations of the cystic fibrosis gene in patients with chronic pancreatitis. N Engl J Med 1998;339:687–88.


11. Pfutzer RH, Barmada MM, Brunskil APJ, et al. SPINK1/PSTI polymorphisms act as disease modifiers in familial and idiopathic chronic pancreatitis. Gastroenterology 2000;119:615–23.


12. Finkelberg DL, Sahani D, Deshpande V, BruggeWR. Autoimmune pancreatitis. New Engl J Med 2006;335:2670–76.


13. Akari T, Ueda M, Ogawa K, Tsuji T. Histological pancreatitis in end-stage renal disease. Int JPancreatology 1992;12:263–69.


14. Mergener K, Baillie J. Chronic pancreatitis. Lancet 1997;340:1379–85.


15. Gullo L, Barbara L, Labo G. Effect of cessation of alcohol use on the course of pancreatic dysfunction in alcoholic pancreatitis. Gastroenterology1988;95:1063–68.


16. Witt H, Apte MV, Keim V, et al. Chronic pancreatitis: challenges and advances in pathogenesis, genetics, diagnosis, and therapy. Gastroenterology 2007;132:1557–73.


17. Ammann RW, Heitz PU, Kloppel G. Course of alcoholic chronic pancreatitis: a prospective clinicomorphological long-term study. Gastroenterology 1996;111:224–31.


18. Ammann RW, Muellhaupt B. Progression of alcoholic acute to chronic pancreatitis. Gut1994;35:552–56.


19. Cahen DL, Gouma DJ, Nio Y, et al. Endoscopic versus surgical drainage of the pancreatic duct in chronic pancreatitis. N Engl J Med 2007;356:676–84.


20. Hayakawa T, Kondo T, Shibata T, et al. Chronic alcoholism and evolution of pain and prognosis in chronic pancreatitis. Dig Dis Sci 1989;34:33–8.


21. Mullhaupt B, Truninger K, Ammann R. Impact of etiology on the painful early stage of chronic pancreatitis: a long-term prospective study. ZGastroenterol 2005;43:1293–301.


22. Thuluvath PJ, Imperio D, Nair S, et al. Chronic pancreatitis. Long-term pain relief with or without surgery, cancer risk, and mortality. J Clin Gastroenterol 2003;36:159–65.


23. Bourliere M, Barthet M, Berthezene P, et al. Is tobacco a risk factor for chronic pancreatitis and alcoholic cirrhosis? Gut 1991;32:1392–95.


24. Lowenfels AB, Zwemer FL, Jhangiani S, et al. Pancreatitis in a native American Indian population. Pancreas 1987;2:694–97.


25. Morton C, Klatsky AL, Udaltsova N. Smoking, coffee, and pancreatitis. Am J Gastroenterol2004;99:731–38.


26. Nakamura Y, Kobayashi Y, Ishikawa A, et al. Severe chronic pancreatitis and severe liver cirrhosis have different frequencies and are independent risk factors in male Japanese alcoholics. J Gastroenterol2004;39:879–87.


27. Rothenbacher D, Low M, Hardt PD, et al. Prevalence and determinants of exocrine pancreatic insufficiency among older adults: results of a population-based study. Scand J Gastroenterol 2005;40:697–704.


28. Talamini G, Vaona B, Bassi C, et al. Alcohol intake, cigarette smoking, and body mass index in patients with alcohol-associated pancreatitis. J Clin Gastroenterol 2000;31:314–17.


29. Yen S, Hsieh CC, MacMahon B. Consumption of alcohol and tobacco and other risk factors for pancreatitis. Am J Epidemiol 1982;116:407–14.


30. Talamini G, Bassi C, Falconi M, et al. Cigarette smoking: an independent risk factor in alcoholic pancreatitis. Pancreas 1996;12:131–37.


31. Imoto M, DiMagno EP. Cigarette smoking increases the risk of pancreatic calcification in late-onset but not early-onset idiopathic chronic pancreatitis. Pancreas 2000;21:115–19.


32. Maisonneuve P, Lowenfels AB, Mullhaupt B, et al. Cigarette smoking accelerates progression of alcoholic chronic pancreatitis. Gut 2005;54:510–14.


33. Scolapio JS, Malhi-Chowla N, Ukleja A. Nutrition supplementation in patients with acute and chronic pancreatitis. Gastroenterol Clin North Am1999;28:695–707.


34. Dutta SK, Bustin MP, Russell RM, et al. Deficiency of fat-soluble vitamins in treated patients with pancreatic insufficiency. Ann Intern Med 1982;97:549–52.


35. Forsmark CE. Chronic pancreatitis and malabsorption. Am J Gastroenterol 2004;99:1355–57.


36. Moran CE, Sosa EG, Martinez SM, et al. Bone mineral density in patients with pancreatic insufficiency and steatorrhea. Am J Gastroenterol1997;92:867–71.


37. Haaber AB, Rosenfalck AM, Hansen B, et al. Bone mineral metabolism, bone mineral density, and body composition in patients with chronic pancreatitis and pancreatic exocrine insufficiency. Int JPancreatol 2000;27:21–7.


38. Ahmad SA, Wray C, Rilo HL, et al. Chronic pancreatitis: recent advances and ongoing challenges. CurrProbl Surg 2006;43:127–38.


39. Winstead NS, Wilcox CM. Clinical trials of pancreatic enzyme replacement for painful chronic pancreatitis – A review. Pancreatology 2009;9:344–50.


40. Brown A, Hughes M, Tenner S, et al. Does pancreatic enzyme supplementation reduce pain in patients with chronic pancreatitis: a meta-analysis. Am J Gastroenterol 1997;92:2032–35.


41. Heijerman HG, Lamers CB, Bakker W. Omeprazole enhances the efficacy of pancreatin (pancrease) in cystic fibrosis. Ann Intern Med 1991;114:200.


42. Vecht J, Symersky T, Lamers CB, Masclee AA. Efficacy of lower than standard doses of pancreatic enzyme supplementation therapy during acid inhibition in patients with pancreatic exocrine insufficiency. J Clin Gastroenterol 2006;40(8):721–25.


43. Nakamura T, Arai Y, Tando Y, et al. Effect of omeprazole on changes in gastric and upper small intestine pH levels in patients with chronic pancreatitis. Clin Ther 1995;17(3):448–59.


44. Lieb JG, Forsmark CE. Review article: pain and chronic pancreatitis. Aliment Pharmacol Ther 2009;29:706–19.


45. Tringali A, Boskoski I, Costamagna G. The role of endoscopy in the therapy of chronic pancreatitis. Best Pract Res Clin Gastroenterol 2008;22:145–65.


46. Niemann T, Madsen LG, Larsen S, et al. Opioid treatment of painful chronic pancreatitis. Int JPancreatol 2000;27:235–40.


47. Bloechle C, Izbicki JR, Knoefel WT, et al. Quality of life in chronic pancreatitis – results after duodenum-preserving resection of the head of the pancreas. Pancreas 1995;11:77–85.


48. Wilder-Smith CH, Hill L, Osler W, et al. Effect of tramadol and morphine on pain and gastrointestinal motor function in patients with chronic pancreatitis. Dig Dis Sci 1999;44:1107–16.


49. Bhardwaj P, Garg PK, Maulik SK, et al. A randomized controlled trial of antioxidant supplementation for pain relief in patients with chronic pancreatitis. Gastroenterology 2009;136:149–59.


50. Dominguez-Munoz JE, Iglesias-Garcia J, Vilarino-Insua M, et al. 13Cmixed triglyceride breath test to assess oral enzyme substitution therapy in patients with chronic pancreatitis. Clin GastroenterolHepatol 2007;5:484–88.


51. Dumasy V, Delhaye M, Cotton F, et al. Fat malabsorption screening in chronic pancreatitis. Am JGastroenterol 2004;99:1350–54.


52. Dominguez-Munoz JE. Pancreatic enzyme therapy for pancreatic exocrine insufficiency. CurrGastroenterol Rep 2007;9:116–22.


53. Waljee AK, Dimagno MJ, Wu BU, et al. Systematic review: pancreatic enzyme treatment of malabsorption associated with chronic pancreatitis. Aliment Pharmacol Ther 2009;29:235–46.


54. Krishnamurty DM, Rabiee A, Jagannath SB, et al. Delayed release pancrelipase for treatment of pancreatic exocrine insufficiency associated with chronic pancreatitis. Ther Clin Risk Management 2009;5:507–20.


55. Kuhnelt P, Mundlos S, Adler G. Effect of pellet size of a pancreas enzyme preparation on duodenal lipolytic activity. Z Gastroenterol 1991;29:417–21.


56. Layer P, Keller J, Lankisch PG. Pancreatic enzyme replacement therapy. Curr Gastroenterol Rep 2001;3:101–08.


57. Dominguez-Munoz JE, Iglesias-Garcia J, Iglesias-Rey M, et al. Optimising the therapy of exocrine pancreatic insufficiency by the association of a proton pump inhibitor to enteric coated pancreatic extracts. Gut 2006;55:1056–57.


58. Trespi E, Ferrieri A. Intestinal bacterial overgrowth during chronic pancreatitis. Curr Med Res Opin1999;15(1):47–52.


59. Czako L, Takacs T, Hegyi P, et al. Quality of life assessment after pancreatic enzyme replacement therapy in chronic pancreatitis. Can J Gastroenterol 2003;17:597–603.


60. Kuhn RJ, Gelrud A, Munck A, Caras S. CREON (Pancrelipase Delayed-Release Capsules) for the treatment of exocrine pancreatic insufficiency. AdvTher 2010;27(12):895–916.


61. Friess H, Kleeff J, Malfertheiner P, et al. Influence of high-dose pancreatic enzyme treatment on pancreatic function in healthy volunteers. Int J Pancreatol1998;23(2):115–23.


62. Malka D, Hammel P, Maire F, et al. Risk of pancreatic adenocarcinoma in chronic pancreatitis. Gut2002;51:849–52.


63. International Expert Committee. International Expert Committee report on the role of the A1c assay in the diagnosis of diabetes. Diabetes Care2009;32:1327–34.


64. Joffe BI, Jackson WPU, Bank S, et al. Effect of oral hypoglycaemic agents on glucose tolerance in pancreatic diabetes. Gut 1972;13:285–88.


Об авторах / Для корреспонденции


Кучерявый Юрий Александрович – кандидат медицинских наук, доцент кафедры пропедевтики внутренних болезней и гастроэнтерологии ГБОУ ВПО “МГМСУ им. А.И. Евдокимова” Минздравсоцразвития России. e-mail: proped@mail.ru


Похожие статьи


Бионика Медиа